QPS Adopts ClinSpark

The Foundry Health team is excited to share another ClinSpark success story. QPS, a global contract research organization (CRO) providing discovery, preclinical and clinical drug development services, recently announced its successful implementation of ClinSpark, an eSource technology platform for Phase I automation, to support double digit growth in Phase I clinical trials.

“ClinSpark will dramatically improve our efficiencies and give our clients immediate access to study data. The faster our clients can access study data, the faster they can make decisions. Timely decisions shorten study timelines and improve outcomes.”

Wim Tamminga, Ph.D., VP, Global Head of Early Phase Clinical, QPS

Close collaboration between QPS and Foundry Health resulted in a successful, four-month implementation timeline.

“There was a strong spirit of cooperation between both teams. At Foundry Health we have a very pragmatic hands-on and solution-oriented attitude and we were very pleased to experience exactly the same on the QPS side.”

Steffan Stringer, Operations Director, Foundry Health

Foundry Health’s founder and CEO observed

“We built ClinSpark to be infinitely scalable to adapt to the dynamic and evolving clinical trial landscape, and we’ve assembled an amazing team to bring the technology to the world. We are delighted to play a role in QPS’ explosive growth story.”

Brock Heinz, CEO, Foundry Health

If you have questions about ClinSpark, please reach out to us via our Contact Us page.